1,556
Views
9
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Thyroid cancer after exposure to radioactive 131I

Pages 1037-1040 | Received 25 Oct 2005, Published online: 08 Jul 2009

References

  • UNITED NATIONS. Sources and effects of ionizing radiation. United Nations Scientific Committee on the Effects of Atomic Radiation, UNSCEAR 2000 Report to the General Assembly, with scientific annexes. United Nations sales publication No. E.00.IX.4 (Volume II: Effects). New York: United Nations: 2000. pp 1220.
  • Ron E, Lubin JH, Shore RE, Mabuchi K, Modan M, Pottern LM, et al. Thyroid cancer after exposure to external radiation: A pooled analysis of seven studies. Radiat Res 1995; 141: 259–77
  • Shore RE. Issues and epidemiological evidence regarding radiation-induced thyroid cancer. Radiat Res 1992; 131: 98–111
  • Holm L-E, Wiklund KE, Lundell GE, Bergman NÅ, Bjelkengren G, Cederquist ES, et al. Thyroid cancer after diagnostic doses of iodine-131: A retrospective cohort study. J Natl Cancer Inst 1988; 80: 1132–8
  • Hall, PA. Mattsson, Boice JD, Jr. Thyroid cancer after diagnostic administration of iodine-131. Radiat Res 1996;145:86–92.
  • Dickman PW, Holm L-E, Lundell G, Boice JD, Jr, Hall P. Thyroid cancer risk after thyroid examination with 131I: A population-based cohort study in Sweden. Int J Cancer 2003; 106: 580–7
  • Hall P, Fürst CJ, Holm L-E, Boice JD, Jr, Inskip P. Thyroid nodularity after diagnostic administration of iodine-131. Radiat Res 1996; 146: 673–82
  • Hamilton PM, Chiacchierini RP, Kaczmarek RG. A follow-up study of persons who had iodine-131 and other diagnostic procedures during childhood. US Department of Health and Human Services, Public Health, Food and Drug Administration, Publication FDA 89–8276, 1989.
  • Hahn K, Schnell-Inderst P, Grosche B, Holm L-E. Thyroid cancer after diagnostic administration of iodine-131 in childhood. Radiat Res 2001; 156: 61–70
  • Kopecky DS, Hamilton TE, Onstad L. Hanford thyroid disease study team. Thyroid neoplasia, autoimmune thyroiditis, and hypothyroidism in persons exposed to iodine 131 from the Hanford nuclear site. JAMA 2004; 292: 2600–13
  • Ron E, Doody MM, Becker DV, Brill AB, Curtis RE, Goldman MB, et al. Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA 1998; 280: 347–55
  • Holm L-E, Hall P, Wiklund K, Lundell G, Berg G, Bjelkengren G, et al. Cancer risk after iodine-131 therapy for hyperthyroidism. J Natl Cancer Inst 1991; 83: 1072–7
  • Hall P, Berg G, Bjelkengren G, Boice JD, Jr, Ericsson U-B, Hallquist A, et al. Cancer mortality after iodine-131 therapy for hyperthyroidism. Int J Cancer 1992; 50: 886–90
  • Franklyn JA, Maisonneuve P, Sheppard M, Betteridge J, Boyle P. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: A population-based cohort study. Lancet 1999; 353: 2111–5
  • Heidenreich WF, Bogdanova TI, Jacob P, Biryukov AG, Tronko ND. Age and time patterns in thyroid cancer after the Chernobyl accidents in the Ukraine. Radiat Res 2000; 154: 731–2
  • Shibata Y, Yamashita S, Masyakin VB, Panasyuk G, Nagataki S. 15 years after Chernobyl: New evidence of thyroid cancer. Lancet 2001; 358: 1965–6
  • Tronko ND, Bogdanova TI, Komissarenko I, Rybakov SI, et al. Thyroid cancer in children and adolescents in Ukraine having been exposed as a result of the Chernobyl accident (15-year expertise of investigations). Int J Radiat Med 2002; 4: 222–32
  • Jacob PY, Kenigsberg I, Zvonova, Goulko G, Buglova E, Heidenreich WF, et al. Childhood exposure due to the Chernobyl accident and thyroid cancer risk in contaminated areas of Belarus and Russia. Br J Cancer 1999; 80: 1461–9
  • Shakhtarin VV, Tsyb AF, Stepanenko VF, Orlov MY, Kopecky KJ, Davis S. Iodine deficiency, radiation dose, and the risk of thyroid cancer among children and adolescents in the Bryansk region of Russia following the Chernobyl power station accident. Int J Epidemiol 2003; 32: 584–91
  • Ivanov VK, Gorski AI, Maksioutov MA, Vlasov OK, Godko AM, Tsyb AF, et al. Thyroid cancer incidence among adolescents and adults in the Bryansk region of Russia following the Chernobyl accident. Health Phys 2003; 84: 46–60
  • Likhtarov I, Kovgan L, Vavilov S, Chepurny M, Bouville A, Luckyaniv N, et al. Post-Chernobyl thyroid cancers in Ukraine. Report 2: Risk analysis. Radiat Res (2005, in press).
  • Astakhova LN, Anspaugh LR, Beebe GW, Bouville A, Drozdovitch VV, Garber V, et al. Chernobyl-related thyroid cancer in children of Belarus: A case-control study. Radiat Res 1998; 150: 349–56
  • Davis S, Stepanenko V, Rivkind N, Kopecky KJ, Voillequé P, Shakhtarin V. A risk of thyroid cancer in the Bryansk oblast of the Russian Federation following the Chernobyl power station accident. Radiat Res 2004; 162: 241–8
  • Cardis E, Kesminiene A, Ivanov V, et al. Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst 2005; 97: 724–32
  • Ivanov VK, Gorski AI, Maksioutov MA, Vlasov OK, Godko AM, Tsyb AF, et al. Thyroid cancer incidence among adolescents and adults in the Bryansk region of Russia following the Chernobyl accident. Health Phys 2003; 84: 46–60
  • Inskip PD, Tekkel M, Rahu M, Veidebaum T, Hakukulinen T, Auvinen A, et al. Studies of leukaemia and thyroid disease among Chernobyl clean-up workers from the Baltics. NCRP Proc 1997; 18: 123–41
  • Ivanov VK, Tsyb AF, Petrov AV, Maksioutov M, Shilyaeva T, Kochergina E. Thyroid cancer incidence among liquidators of the Chernobyl accident. Absence of dependence of radiation risks on external radiation dose. Radiat Environ Biophys 2002; 41: 195–8
  • Ivanov VK, Tsyb AF, Gorsky AI, Maksioutov M, Rastopchin EM, Konogorov AP, et al. Leukaemia and thyroid cancer in emergency workers of the Chernobyl accident: Estimation of radiation risks (1986–1988). Radiat Environ Biophys 1997; 36: 9–16
  • Rahu M, Tekkel M, Veidebaum T, Pukkala E, Hakulinen T, Auvinen A, et al. The Estonian study of Chernobyl cleanup workers: II. Incidence of cancer and mortality. Radiat Res 1997; 147: 653–7
  • Boice JD, Jr. Radiation-induced thyroid cancer-What's new? Editorial. J Nat Cancer Inst 2005; 97: 703–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.